Showing results (131-140 of 163) with videos related to

Sort By:
Pageof 17
Lancet (London, England)|November 11, 2024
Betibeglogene autotemcel gene therapy in patients with transfusion-dependent, severe genotype β-thalassaemia (HGB-212): a non-randomised, multicentre, single-arm, open-label, single-dose, phase 3 trialJanet L Kwiatkowski, Mark C Walters, Suradej Hongeng, et al.
Behaviour Research and Therapy|October 4, 2014
The effectiveness of an attention bias modification program as an adjunctive treatment for Post-Traumatic Stress DisorderJennie M Kuckertz, Nader Amir, Joseph W Boffa, et al.
Contemporary Clinical Trials Communications|July 25, 2019
Design for a cohort-randomized trial of an acceptance and commitment therapy-enhanced weight management and fitness program for Navy personnelNiloofar Afari, Jessica Gundy Cuneo, Matthew Herbert, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 29, 2018
Unrelated Donor Transplantation in Children with Thalassemia using Reduced-Intensity Conditioning: The URTH TrialShalini Shenoy, Mark C Walters, Alex Ngwube, et al.
Blood|June 26, 2004
FCGR3A and FCGR2A polymorphisms may not correlate with response to alemtuzumab in chronic lymphocytic leukemiaThomas S Lin, Ian W Flinn, Rama Modali, et al.
Transfusion|April 18, 2018
Hemoglobin A clearance in children with sickle cell anemia on chronic transfusion therapyMarianne E M Yee, Cassandra D Josephson, Anne M Winkler, et al.
Haematologica|April 16, 2013
Sildenafil therapy in thalassemia patients with Doppler-defined risk of pulmonary hypertensionClaudia R Morris, Hae-Young Kim, John Wood, et al.
Transfusion|June 26, 2020
Red cell exchange for patients with sickle cell disease: an international survey of current practicesMatthew S Karafin, Jeanne E Hendrickson, Haewon C Kim, et al.
The New England Journal of Medicine|September 5, 2019
Safety and Efficacy of Mitapivat in Pyruvate Kinase DeficiencyRachael F Grace, Christian Rose, D Mark Layton, et al.
American Journal of Hematology|December 1, 2015
Effects of hydroxyurea treatment for patients with hemoglobin SC diseaseLori Luchtman-Jones, Sara Pressel, Lee Hilliard, et al.
Pageof 17